Analysis of the Cancer Genome Atlas (TCGA) revealed that high IRF8 and STING levels were significantly correlated with the beneficial prognosis of cancer patients, such as lung adenocarcinoma, liver cancer and sarcoma (Fig. S6d). This evidence concerns the gene IRF8 and cancer.